|
KHNYN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.461300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.487900E-02 |
| Normal-vs-Stage2 |
8.802700E-04 |
| Normal-vs-Stage3 |
3.198900E-03 |
| Normal-vs-Stage4 |
1.024770E-01 |
| Stage1-vs-Stage2 |
4.185700E-02 |
| Stage1-vs-Stage3 |
1.020610E-01 |
| Stage1-vs-Stage4 |
8.590800E-01 |
| Stage2-vs-Stage3 |
3.353800E-01 |
| Stage2-vs-Stage4 |
1.145230E-01 |
| Stage3-vs-Stage4 |
3.353400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.349900E-02 |
| Normal-vs-AfricanAmerican |
4.963200E-01 |
| Normal-vs-Asian |
1.973630E-01 |
| Caucasian-vs-AfricanAmerican |
4.831000E-01 |
| Caucasian-vs-Asian |
5.935800E-01 |
| AfricanAmerican-vs-Asian |
7.004600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.417690E-02 |
| Normal-vs-Female |
8.796700E-03 |
| Male-vs-Female |
7.557600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.550760E-01 |
| Normal-vs-Age(41-60Yrs) |
4.682200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.160700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.873560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.098750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.140200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.167800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.177600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.136800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.103000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.777800E-02 |
| Classical-VS-Follicular |
1.18110000002503E-07 |
| Classical-VS-Other |
3.417800E-01 |
| Classical-VS-Normal |
3.138000E-01 |
| Tall-VS-Follicular |
6.446200E-02 |
| Tall-VS-Other |
9.071200E-01 |
| Tall-VS-Normal |
1.623700E-02 |
| Follicular-VS-Other |
4.677600E-01 |
| Follicular-VS-Normal |
2.55189999998073E-06 |
| Other-VS-Normal |
1.358790E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.955600E-04 |
| Normal-vs-N1 |
1.143410E-01 |
| N0-vs-N1 |
2.598200E-01 |
|
|
